about
Mechanism of the Anticoagulant Activity of Thrombin Mutant W215A/E217ARigidification of the autolysis loop enhances Na+ binding to thrombinLatest medical treatment strategies for venous thromboembolism.Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIaThe story of the discovery of heparin and warfarin.Update on anti-coagulation in atrial fibrillation.Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants.Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trialsThrombin.Serpins in thrombosis, hemostasis and fibrinolysisBemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism.Developments in factor Xa inhibitors for the treatment of thromboembolic disorders.Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.Alternatives to warfarin--the next generation of anticoagulants.Rational design of novel red-shifted BRET pairs: Platforms for real-time single-chain protease biosensors.Heparin: new life for an old drug.Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.Management of bleeding in patients taking FXa and FIIa inhibitors.Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation.Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants.
P2860
Q27646504-D84A5AAE-AB3F-4B50-972F-662935140B55Q27667649-3C4BA511-51BA-4D74-9984-4D70A018DC25Q33375535-834207F3-D0A5-42BA-8412-CE0FE7D0A3C6Q34547334-981D97DB-D474-46F4-8858-006D79F6EA86Q34763634-C198B49A-9015-427D-B909-4B04404BF34EQ35172841-56B48323-C9B7-4CCE-8FA0-FCC596F61304Q35752608-0C01434A-9A3E-4A75-8B22-39289FECB378Q35938914-7ABE7194-DA1D-442F-AABA-E66C04DD797EQ36736060-01CC4CAD-4E65-47D3-81F7-1790F627F447Q36800534-6C1314D8-972A-4626-B6D1-39FF4325DA63Q36884340-17EFAE49-06E8-4F81-AAE1-24E5D2008C7BQ37197069-382C90C4-99C8-4B2E-850E-C615AB25F7A9Q37646551-A619B43A-3039-4372-8C41-22A42C73329CQ37743508-7FDE1F26-A4A3-4BDD-9EB6-622CBB14F807Q37772227-FF4E19FB-17B3-4029-BBA4-223420B13760Q39226867-7A276445-0DAB-4BC9-B27A-A688793E39BDQ40164066-AE0947D6-4CE6-41BB-8B65-C4B28BB6B9D4Q43774366-DBAD8B53-B8D1-4C92-A9BC-6F49B65894B5Q45007433-36F91B04-699F-4746-BBD5-9D5B1CEAE95FQ47290768-32C91509-80EE-40CD-A9A1-7C1985E98E42Q53168179-F5A51CF7-7D65-4EA6-B858-9E1E0E06BEA9
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The status of new anticoagulants.
@ast
The status of new anticoagulants.
@en
type
label
The status of new anticoagulants.
@ast
The status of new anticoagulants.
@en
prefLabel
The status of new anticoagulants.
@ast
The status of new anticoagulants.
@en
P2860
P1476
The status of new anticoagulants.
@en
P2093
Jeffrey I Weitz
Shannon M Bates
P2860
P356
10.1111/J.1365-2141.2006.06134.X
P407
P577
2006-07-01T00:00:00Z